238 related articles for article (PubMed ID: 38529392)
61. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
[TBL] [Abstract][Full Text] [Related]
62. Thromboembolic disease in hypercortisolism.
Capatina C; Fleseriu M
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):330-336. PubMed ID: 33741780
[TBL] [Abstract][Full Text] [Related]
63. A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease.
Kemp MT; Obi AT; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1557-1567. PubMed ID: 33866055
[TBL] [Abstract][Full Text] [Related]
64. Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia.
Boonyawat K; Angchaisuksiri P
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):474-480. PubMed ID: 36485150
[TBL] [Abstract][Full Text] [Related]
65. Incidence of venous thromboembolism and bleeding after pulmonary lobectomy: evaluating the timing for thromboprophylaxis.
Smith D; Raices M; Diego C; Julián D; Montagne J; Dietrich A
J Thromb Thrombolysis; 2021 May; 51(4):997-1004. PubMed ID: 32929687
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease.
Ferrante E; Serban AL; Clerici M; Indirli R; Scalambrino E; Carosi G; Padovan L; Locatelli M; Arosio M; Peyvandi F; Mantovani G; Tripodi A
J Endocrinol Invest; 2022 Jan; 45(1):9-16. PubMed ID: 34115342
[TBL] [Abstract][Full Text] [Related]
67. VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines.
Abukhalil AD; Nasser A; Khader H; Albandak M; Madia R; Al-Shami N; Naseef HA
Vasc Health Risk Manag; 2022; 18():701-710. PubMed ID: 36082196
[TBL] [Abstract][Full Text] [Related]
68. Topical issues in venous thromboembolism.
Abad Rico JI; Llau Pitarch JV; Páramo Fernández JA
Drugs; 2010 Dec; 70 Suppl 2():11-8. PubMed ID: 21162605
[TBL] [Abstract][Full Text] [Related]
69. Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
Zhang D; Jiang Y; Lu L; Lu Z; Xia W; Xing X; Fan H
Front Endocrinol (Lausanne); 2021; 12():640998. PubMed ID: 33854481
[TBL] [Abstract][Full Text] [Related]
70. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
Tufano A; Brenner B
Semin Thromb Hemost; 2024 Feb; 50(1):96-103. PubMed ID: 37201536
[TBL] [Abstract][Full Text] [Related]
71. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
[TBL] [Abstract][Full Text] [Related]
72. Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study.
Kemp M; Chan AHY; Harrison J; Rogers H; Zhao A; Kaur H; Tang G; Yang E; Beyene K
Int J Clin Pharm; 2023 Aug; 45(4):864-874. PubMed ID: 37074512
[TBL] [Abstract][Full Text] [Related]
73. Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?
Middeldorp S; Naue C; Köhler C
Hamostaseologie; 2022 Feb; 42(1):54-64. PubMed ID: 35196731
[TBL] [Abstract][Full Text] [Related]
74. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
75. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma.
Bravo-Perez C; Fernández-Caballero M; Soler-Espejo E; Garcia-Torralba E; Sorigue M; García-Malo MD; Jerez A; Vicente V; Roldán V; de Arriba F
J Thromb Thrombolysis; 2021 Oct; 52(3):848-853. PubMed ID: 33649980
[TBL] [Abstract][Full Text] [Related]
76. Venous thromboprophylaxis in gastrointestinal bleeding.
Malhotra N; Chande N
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):145-8. PubMed ID: 25855878
[TBL] [Abstract][Full Text] [Related]
77. Venous thromboembolism in cystic fibrosis.
Takemoto CM
Pediatr Pulmonol; 2012 Feb; 47(2):105-12. PubMed ID: 22006666
[TBL] [Abstract][Full Text] [Related]
78. Overview of venous thromboembolism.
Abad Rico JI; Llau Pitarch JV; Rocha E
Drugs; 2010 Dec; 70 Suppl 2():3-10. PubMed ID: 21162604
[TBL] [Abstract][Full Text] [Related]
79. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
80. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the elderly.
Kozek-Langenecker S; Fenger-Eriksen C; Thienpont E; Barauskas G;
Eur J Anaesthesiol; 2018 Feb; 35(2):116-122. PubMed ID: 28901992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
